Since animal experiments indicate that sKL reductions per se can contribute to cardiac injury (80, 107, 165, 169), it would be important to conduct studies in the absence of FGF23 in order to determine whether in the context of CKD, FGF23 elevations are required for the induction of cardiac injury. Here, FGF23 is linked to chronic kidney disease.